Amyloid A amyloidosis in a Japanese patient with familial Mediterranean fever associated with homozygosity for the pyrin variant M694I/M694I

References

• Ozen S. Changing concepts in familial Mediterranean fever. is it possible to have an autosomal-recessive disease with only one mutation? Arthritis Rheum. 2009;60: 1575–1577.
   PubMedGoogle Scholar
• Drenth JPH, Meer JWM. Hereditary periodic fever. N Engl J Med. 2001;345: 1748–1757.
   PubMed Web of Science ®Google Scholar
• Grateau G. The relation between familial Mediterranean fever and amyloidosis. Curr Opin Rheumatol. 2000;12: 61–64.
   PubMed Web of Science ®Google Scholar
• Tsuchiya-Suzuki A, Yazaki M, Nakamura A, Yamazaki K, Agematsu K, Matsuda M, et al. Clinical and genetic features of familial Mediterranean fever in Japan. J Rheumatol. 2009;36: 1671–1676.
   PubMed Web of Science ®Google Scholar
• Tanaka M, Migita K, Miyashita T, Maeda Y, Nakamura M, Komori A, et al. Coexistence of familial Mediterranean fever and Sjögren’s syndrome in a Japanese patient. Clin Exp Rheumatol. 2007;25: 792.
   PubMed Web of Science ®Google Scholar
• Nakamura T, Higashi S, Tomoda K, Tsukano M, Baba S, Shono M. Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis. Rheumatology (Oxford). 2006;45: 43–49.
   PubMed Web of Science ®Google Scholar
• Nakamura T, Amyloid A. amyloidosis secondary to rheumatoid arthritis: development of pathophysiology and treatments. Clin Exp Rheumatol. 2011;29: 850–857.
   PubMed Web of Science ®Google Scholar
• Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1998;40: 1879–1885.
   Google Scholar
• Touitou I, Sarkisian T, Medlej-Hashim M, Tunca M, Livneh A, Cattan D, et al. Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum. 2007;56: 1706–1712.
   PubMed Web of Science ®Google Scholar
• Tuglular S, Yalcinkaya F, Paydas S, Oner A, Utas C, Bozfakkioglu S, et al. A retrospective analysis for aetiology and clinical findings of 287 secondary amyloidosis cases in Turkey. Nephrol Dial Transplant. 2002;17: 2003–2005.
   PubMed Web of Science ®Google Scholar
• Gershoni-Baruch R, Birk R, Zacks N, Shinawi M, Lidar M, Livneh A. The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever. Arthritis Rheum. 2003;48: 1149–1155.
   PubMed Web of Science ®Google Scholar
• Tomiyama N, Oshiro S, Higashiuesato Y, Yamazato M, Sakima A, Tana T, et al. End-stage disease associated with familial Mediterranean fever. Intern Med. 2002;41: 221–224.
   PubMed Web of Science ®Google Scholar
• Kutlugun AA, Yildirim T, Altindal M, Arici M, Yasavul U, Turgan C. AA type renal amyloidosis secondary to FMF: a long-term follow-up in two patients. Renal Fail. 2010;32: 1230–1232.
   PubMed Web of Science ®Google Scholar
• Ohshima K, Yamazaki K, Nakajima Y, Kobayashi A, Kato T, Ohara O, et al. A case of familial Mediterranean fever associated with compound heterozygosity for the pyrin variant L110P–E148Q/M680I in Japan. Mod Rheumatol. 2010;20: 193–195.
   PubMed Web of Science ®Google Scholar
• Sugiura T, Kawaguchi Y, Fujikawa S, Hirano Y, Igarashi T, Kawamoto M, et al. Familial Mediterranean fever in three Japanese patients, and a comparison of the frequency of MEFV gene mutations in Japanese and Mediterranean populations. Mod Rheumatol. 2008;18: 57–59.
   PubMed Web of Science ®Google Scholar
• Cazeneuve C, Ajrapetyan H, Papin S, Roudot-Thoraval F, Gnevieve D, Mndjoyan E, et al. Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. Am J Hum Genet. 2000;67: 1136–1143.
   PubMed Web of Science ®Google Scholar
• Moriguchi M, Terai C, Kaneko H, Koseki Y, Kajiyama H, Uesato M, et al. A novel single-nucleotide polymorphism at the 5′-flanking region of SAA1 associated with risk of type AA amyloidosis secondary to rheumatoid arthritis. Arthritis Rheum. 2001;44: 1266–1272.
   PubMed Web of Science ®Google Scholar
• Pras M, Bronshpigel N, Xemer D, Gafni J. Variable incidence of amyloidosis in familial Mediterranean fever among different ethnic groups. John Hopkins Med J. 1982;150: 22–26.
   PubMedGoogle Scholar
• Livneh A, Langevitz P, Shinar Y, Zaks N, Kastner DL, Pras M, et al. MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever. Amyloid. 1999;6: 1–6.
   PubMed Web of Science ®Google Scholar
• Akar N, Hasipek M, Akar E, Ekim M, Yalcinkaya F, Cakar N. Serum amyloid A1 and tumor necrosis factor-alpha alleles in Turkish familial Mediterranean fever patients with and without amyloidosis. Amyloid. 2003;10: 12–16.
   PubMed Web of Science ®Google Scholar
• Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med. 1986;314: 1001–1005.
   PubMed Web of Science ®Google Scholar
• Tuglular S, Bihorac A, Ozener IC, Akoglu E. Does colchicine also induce a clearance of the established amyloid deposits? Nephrol Dial Transplant. 1999;14: 1042–1043.
   PubMed Web of Science ®Google Scholar
• Duzgun N, Sahin M, Akar N, Kuzu I, Ensari A, Tulunay O. Complete remission of nephritic syndrome in secondary amyloidosis of familial Mediterranean fever following colchicine treatment. Ankara Univ Tip Fakul Mec. 2005;58: 136–138.
   Google Scholar
• Hausmann M, Maor E, Kachko L. Colchicine-sensitive nephritic syndrome due to AA amyloidosis. Amyloid. 2011;18: 169–171.
   PubMed Web of Science ®Google Scholar
• Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet. 2001;358: 24–29.
   PubMed Web of Science ®Google Scholar